2023 Outlook for China’s NRDL

The three notable themes with this year’s national reimbursement drug (NRDL) list in China. 

Organizing commercial teams to boost sales

The economic outlook continues to be volatile for B2B companies and it is in these times that we count most on our sales force to secure profitable volumes.

3 key reasons to use market segmentation as a strategic tool

Market segmentation is a powerful strategic tool that every business should utilize to drive success. Companies can gain insights and make decisions by dividing the market into segments, helping them stay ahead of the competition.

Driving behavior through customer incentives

China: Partnering for innovations in commercial health insurance  

China commercial health insurance (CHI) features vibrant growth on one hand, and complexities and variances on the other. A strategic approach is key for major pharma and medtech pharmaceutical firms to prioritize CHI opportunities, and to take part in the ongoing optimizations and innovations. 

Retail investment study 2024: Business models at a tipping point?

Train your pricing muscle